Form 8-K - Current report:
SEC Accession No. 0001193805-20-000622
Filing Date
2020-05-21
Accepted
2020-05-21 16:34:45
Documents
2
Period of Report
2020-05-20
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e619655_8k-at.htm 8-K 18215
2 e619655_ex99-1.htm EX-99.1 12648
  Complete submission text file 0001193805-20-000622.txt   32061
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 20902336
SIC: 2834 Pharmaceutical Preparations